Damon DeSantis - Jul 18, 2023 Form 4 Insider Report for INTEGRATED BIOPHARMA INC (INBP)

Role
Director
Signature
/s/ Damon DeSantis
Stock symbol
INBP
Transactions as of
Jul 18, 2023
Transactions value $
$0
Form type
4
Date filed
7/19/2023, 03:27 PM
Previous filing
Mar 27, 2023
Next filing
Mar 5, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INBP Stock Option (right to buy) Award $0 +50K $0.00 50K Jul 18, 2023 Common Stock 50K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exercise price of each stock option will be the closing price of the Issuer's Common Stock on July 25, 2023, which represents the fifth trading day after the grant date.
F2 The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2023, December 31, 2023, March 31, 2024 and June 30, 2024.